BMJ  2004;328:791 (3 April), doi:10.1136/bmj.38049.490255.DE (published 16 March 2004)

Paper

Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial

Objective To assess the efficacy of three days versus five days of treatment with oral amoxicillin for curing non-severe pneumonia in children.

Design Randomised, double blind, placebo controlled multicentre trial.

Setting Outpatient departments of seven referral hospitals in India.

Participants 2188 children aged 2-59 months, 1095 given three days of treatment and 1093 given five days.

Intervention Oral amoxicillin 31-54 mg/kg/day in three divided doses.

Main outcome measures Treatment failure: defined as development of chest indrawing, convulsions, drowsiness, or inability to drink at any time; respiratory rate above age specific cut points on day 3 or later; or oxygen saturation by pulse oximetry < 90% on day 3.

Results The clinical cure rates with three days and five days of treatment were 89.5% and 89.9%, respectively (absolute difference 0.4 (95% confidence interval - 2.1 to 3.0)). Adherence to treatment regimen was 94% and 85% for three day and five day treatments, respectively. Loss to follow up was 5.4% by day 5. There were no deaths, 41 hospitalisations, and 36 minor adverse reactions. There were 225 (10.3%) clinical failures and 106 (5.3%) relapses, and rates were similar in both treatments. At enrolment, 513 (23.4%) children tested positive for respiratory syncytial virus, and Streptococcus pneumoniae and Haemophilus influenzae were isolated from the nasopharynx in 878 (40.4%) and 496 (22.8%) children, respectively. Clinical failure was associated with isolation of respiratory syncytial virus (adjusted odds ratio 1.95 (95% confidence interval 1.0 to 3.8)), excess respiratory rate of > 10 breaths/minute (2.89 (1.83 to 4.55)), and non-adherence with treatment at day 5 (11.57 (7.4 to 18.0)).

Conclusions Treatment with oral amoxicillin for three days was as effective as for five days in children with non-severe pneumonia.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study

Rachida el Moussaoui, Corianne A J M de Borgie, Peterhans van den Broek, Willem N Hustinx, Paul Bresser, Guido E L van den Berk, Jan-Werner Poley, Bob van den Berg, Frans H Krouwels, Marc J M Bonten, Carla Weenink, Patrick M M Bossuyt, Peter Speelman, Brent C Opmeer, and Jan M Prins
BMJ 2006 332: 1355. [Abstract] [Full Text] [PDF]

Amoxicillin for non-severe pneumonia in young children: Stop skimping, start investing in antibiotic treatment

Lynne Wrennall
BMJ 2004 328: 1566-1567. [Extract] [Full Text]

Amoxicillin for non-severe pneumonia in young children: Admission to hospital may indicate adverse effects

Javier Borja and David Rigau
BMJ 2004 328: 1567. [Extract] [Full Text]

Three days of amoxicillin are enough for non-severe pneumonia
BMJ 2004 328: 0. [Full Text]

Is there hope for South Asia?

Zulfiqar Bhutta, Samiran Nundy, and Kamran Abbasi
BMJ 2004 328: 777-778. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Awasthi, S., Agarwal, G., Singh, J. V., Kabra, S. K., Pillai, R. M., Singhi, S., Nongkynrih, B., Dwivedi, R., More, V. B., Kulkarni, M., Niswade, A. K., Bharti, B., Ambast, A., Dhasmana, P., ICMR-IndiaClen Pneumonia Project Group, (2008). Effectiveness of 3-Day Amoxycillin vs. 5-Day Co-trimoxazole in the Treatment of Non-severe Pneumonia in Children Aged 2-59 Months of Age: A Multi-centric Open Labeled Trial. J Trop Pediatr 54: 382-389 [Abstract] [Full text]  
• El Moussaoui, R, Roede, B M, Speelman, P, Bresser, P, Prins, J M, Bossuyt, P M M (2008). Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax 63: 415-422 [Abstract] [Full text]  
• Kardas, P. (2007). Comparison of patient compliance with once-daily and twice-daily antibiotic regimens in respiratory tract infections: results of a randomized trial. J Antimicrob Chemother 59: 531-536 [Abstract] [Full text]  
• el Moussaoui, R., de Borgie, C. A J M, van den Broek, P., Hustinx, W. N, Bresser, P., van den Berk, G. E L, Poley, J.-W., van den Berg, B., Krouwels, F. H, Bonten, M. J M, Weenink, C., Bossuyt, P. M M, Speelman, P., Opmeer, B. C, Prins, J. M (2006). Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study.. BMJ 332: 1355-1355 [Abstract] [Full text]  
• (2004). 23 Apr 2004 to 23 Jul 2004. Evid. Based Nurs. 7: e4-e4 [Full text]  
• Lakhanpaul, M., Atkinson, M., Stephenson, T. (2004). Community acquired pneumonia in children: a clinical update. EDUCATION AND PRACTICE 89: ep29-ep34 [Full text]  
• (2004). Other articles noted. Evid. Based Med. 9: e5-e5 [Full text]  
• (2004). Journal Watch. Arch. Dis. Child. 89: 888-889 [Full text]  
• Borja, J., Rigau, D. (2004). Amoxicillin for non-severe pneumonia in young children: Admission to hospital may indicate adverse effects. BMJ 328: 1567-1567 [Full text]  
• Wrennall, L. (2004). Amoxicillin for non-severe pneumonia in young children: Stop skimping, start investing in antibiotic treatment. BMJ 328: 1566-1567 [Full text]  
• (2004). Short-Course Amoxicillin for Outpatient Pneumonia in Children. JWatch Emergency Med. 2004: 6-6 [Full text]  
• (2004). Treating Childhood Pneumonia: How Many Days?. JWatch General 2004: 2-2 [Full text]  

Rapid Responses:

Read all Rapid Responses

Biophysical Semeiotics and Single Patient Based Medicine: “What do they mean?”.

Sergio Stagnaro
bmj.com, 2 Apr 2004 [Full text]

Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children

Javier Borja, et al.
bmj.com, 7 Apr 2004 [Full text]

A discrepancy?

Sarah H Pennington
bmj.com, 8 Apr 2004 [Full text]

Discrepancy between the results of antibiotic susceptibility pattern and the clinical outcome rates

Abid Mahmood, et al.
bmj.com, 9 Apr 2004 [Full text]

?not pneumonia

Eric Chan
bmj.com, 14 Apr 2004 [Full text]

Stop Skimping, Start Investing

Dr Lynne Wrennall
bmj.com, 25 Apr 2004 [Full text]

Online poll

Find out more on doc2doc >>